Literature DB >> 23673432

Couples at risk for spinocerebellar ataxia type 2: the Cuban prenatal diagnosis experience.

Tania Cruz-Mariño1, Luis Velázquez-Pérez, Yanetza González-Zaldivar, Raúl Aguilera-Rodríguez, Miguel Velázquez-Santos, Yaimé Vázquez-Mojena, Annelié Estupiñán-Rodríguez, Rubén Reynaldo-Armiñán, Luis Enrique Almaguer-Mederos, José Miguel Laffita-Mesa, Victor Tamayo-Chiang, Milena Paneque.   

Abstract

Cuba reports the highest worldwide prevalence of spinocerebellar ataxia type 2 (SCA2) and the greatest number of descendants at risk. A protocol for genetic counseling, presymptomatic testing, and prenatal diagnosis of hereditary ataxias has been under development since 2001. Considering that the revision of the experience with prenatal diagnosis for SCA2 in Cuba would enable comparison of ours with international findings, we designed a descriptive study, based on the retrospective revision of the medical records belonging to the 58 couples that requested their inclusion in the program, during an 11-year period (2001-2011). Most of the participants in the prenatal diagnosis program were known presymptomatic carriers, diagnosed through the presymptomatic testing in the same period of study, for an uptake among them of 22.87 % (51 out of 223). In 28 cases, the fetuses were carriers, 20 of these couples (71.43 %) decided to terminate the pregnancy; the rest continued the pregnancy to term, this resulting in a predictive test for their unborn children. A predominance of females as the at-risk progenitor was observed. Except for a slightly lower average age, the results attained in the Cuban SCA2 prenatal diagnosis program resulted similar to the ones reported for Huntington disease in other countries. It is necessary to have easy access to the Cuban program through its expansion to other genetic centers along the island. Future research is needed to evaluate the long-term impact of both the predictive testing in unborn children and the selection of other reproductive options by the at-risk couples.

Entities:  

Year:  2013        PMID: 23673432      PMCID: PMC3773317          DOI: 10.1007/s12687-013-0147-z

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  45 in total

1.  The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.

Authors:  A Erez; K Plunkett; V R Sutton; A L McGuire
Journal:  Am J Med Genet A       Date:  2010-07       Impact factor: 2.802

2.  Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing.

Authors:  Caroline Santa Maria Rodrigues; Viviane Ziebell de Oliveira; Gabriela Camargo; Claudio Maria da Silva Osório; Raphael Machado de Castilhos; Maria Luiza Saraiva-Pereira; Lavínia Schuler-Faccini; Laura Bannach Jardim
Journal:  J Genet Couns       Date:  2011-06-30       Impact factor: 2.537

3.  Prenatal testing for Huntington's disease: a European collaborative study.

Authors:  Sheila A Simpson; Moniek W Zoeteweij; Kurt Nys; Peter Harper; Alexandra Dürr; Gioia Jacopini; Christos Yapijakis; Gerry Evers-Kiebooms
Journal:  Eur J Hum Genet       Date:  2002-11       Impact factor: 4.246

4.  The genetic testing of children. Working Party of the Clinical Genetics Society (UK)

Authors:  A Clarke
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

5.  Huntington's disease in Greece: the experience of 14 years.

Authors:  M Panas; G Karadima; E Vassos; N Kalfakis; A Kladi; K Christodoulou; D Vassilopoulos
Journal:  Clin Genet       Date:  2010-12-20       Impact factor: 4.438

6.  The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from.

Authors:  T Cruz-Mariño; L Velázquez-Pérez; Y González-Zaldivar; R Aguilera-Rodríguez; M Velázquez-Santos; Y Vázquez-Mojena; A Estupiñán-Rodríguez; J M Laffita-Mesa; R Reynaldo-Armiñán; L E Almaguer-Mederos; M Paneque
Journal:  Clin Genet       Date:  2013-06       Impact factor: 4.438

7.  Attitudes towards predictive testing in Huntington's disease: a recent survey in Belgium.

Authors:  G Evers-Kiebooms; J J Cassiman; H van den Berghe
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

8.  Presymptomatic diagnosis in Huntington's disease: the Mexican experience.

Authors:  Maria Elisa Alonso; Adriana Ochoa; Ana Luisa Sosa; Yaneth Rodríguez; Mireya Chávez; Catherine Boll; Petra Yescas; Rosario Macías; Astrid Rasmussen
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

9.  Five year study of prenatal testing for Huntington's disease: demand, attitudes, and psychological assessment.

Authors:  S Adam; S Wiggins; P Whyte; M Bloch; M H Shokeir; H Soltan; W Meschino; A Summers; O Suchowersky; J P Welch
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

10.  Ethical and social issues in presymptomatic testing for Huntington's disease: a European Community collaborative study. European Community Huntington's Disease Collaborative Study Group.

Authors: 
Journal:  J Med Genet       Date:  1993-12       Impact factor: 6.318

View more
  4 in total

Review 1.  A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.

Authors:  Felicity Wadrup; Simon Holden; Rhona MacLeod; Zosia Miedzybrodzka; Andrea H Németh; Shan Owens; Sara Pasalodos; Oliver Quarrell; Angus J Clarke
Journal:  Eur J Hum Genet       Date:  2019-03-19       Impact factor: 4.246

2.  SCA2 predictive testing in Cuba: challenging concepts and protocol evolution.

Authors:  Tania Cruz-Mariño; Yaimeé Vázquez-Mojena; Luis Velázquez-Pérez; Yanetza González-Zaldívar; Raúl Aguilera-Rodríguez; Miguel Velázquez-Santos; Annelié Estupiñán-Rodríguez; José Miguel Laffita-Mesa; Luis E Almaguer-Mederos; Milena Paneque
Journal:  J Community Genet       Date:  2015-04-19

3.  Bioethical issues of preventing hereditary diseases with late onset in the Sakha Republic (Yakutia).

Authors:  Sardana K Kononova; Oksana G Sidorova; Sardana A Fedorova; Fedor A Platonov; Vera L Izhevskaya; Elza K Khusnutdinova
Journal:  Int J Circumpolar Health       Date:  2014-07-24       Impact factor: 1.228

4.  Genes and genetic testing in hereditary ataxias.

Authors:  Erin Sandford; Margit Burmeister
Journal:  Genes (Basel)       Date:  2014-07-22       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.